Both anti-TNF and non-anti-TNF biologics were associated with reduced risk of anxiety/depression compared with non-AT therapy (both HR 0.8; <i>p</i> < 0.001 and <i>p</i> = 0.004, respectively). Here, TNF is linked to major depressive disorder.